Latest filings (excl ownership)
No filings
Latest ownership filings
4
Emergent BioSolutions Inc.
28 May 24
4
Syndax Pharmaceuticals Inc
9 Feb 24
4
Emergent BioSolutions Inc.
30 May 23
4
Eledon Pharmaceuticals, Inc.
2 May 23
4
Syndax Pharmaceuticals Inc
3 Feb 23
4
Eledon Pharmaceuticals, Inc.
2 Feb 23
4
Syndax Pharmaceuticals Inc
7 Oct 22
4
Syndax Pharmaceuticals Inc
4 Oct 22
4
Emergent BioSolutions Inc.
5 Apr 22
3
Emergent BioSolutions Inc.
5 Apr 22
4
Syndax Pharmaceuticals Inc
3 Feb 22
4
Eledon Pharmaceuticals, Inc.
2 Feb 22
4
RIGEL PHARMACEUTICALS INC
21 May 21
4
Syndax Pharmaceuticals Inc
5 Feb 21
4
Novus Therapeutics, Inc.
15 Sep 20
4
RIGEL PHARMACEUTICALS INC
15 May 20
4
Urovant Sciences Ltd.
21 Feb 20
4
Syndax Pharmaceuticals Inc
14 Feb 20
4
Urovant Sciences Ltd.
9 Jan 20
4
Urovant Sciences Ltd.
11 Dec 19
4
Novus Therapeutics, Inc.
15 Jul 19
4
Syndax Pharmaceuticals Inc
12 Jun 19
4
RIGEL PHARMACEUTICALS INC
24 May 19
4
Urovant Sciences Ltd.
8 Jan 19
4
Urovant Sciences Ltd.
17 Oct 18
4
Urovant Sciences Ltd.
3 Oct 18
4
Urovant Sciences Ltd.
28 Sep 18
3
Urovant Sciences Ltd.
26 Sep 18
4
Novus Therapeutics, Inc.
14 Jun 18
4
Syndax Pharmaceuticals Inc
25 May 18
4
RIGEL PHARMACEUTICALS INC
18 May 18
4
Syndax Pharmaceuticals Inc
12 Feb 18
4
Novus Therapeutics, Inc.
5 Jul 17
4
Syndax Pharmaceuticals Inc
19 May 17
4
RIGEL PHARMACEUTICALS INC
12 May 17
3
Novus Therapeutics, Inc.
11 May 17
3
Syndax Pharmaceuticals Inc
31 Mar 17
4
Syndax Pharmaceuticals Inc
31 Mar 17
4
RIGEL PHARMACEUTICALS INC
12 May 16
4
Carbylan Therapeutics, Inc.
5 Aug 15